Multidrug-resistant Tuberculosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-12-02
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis [Phase 3]
A Phase 3 trial evaluating TMC207 (bedaquiline) for pulmonary multidrug-resistant tuberculosis has been withdrawn.